Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Mashup Score: 2

Blood Cancer Journal

This study shows that production of neutralizing antibodies against COVID are low in patients with myeloma, and impaired especially in patients receiving anti CD38

  • This study shows that production of neutralizing antibodies against COVID are low in patients with myeloma, and impaired especially in patients receiving anti CD38 antibodies or belantamab.